Description of Business (Details) $ in Millions	Oct. 01, 2019 USD ($) shares	Dec. 31, 2019 pharmacy
Business Acquisition [Line Items]
Number of stores (in pharmacies) | pharmacy		1
Progenics Pharmaceuticals
Business Acquisition [Line Items]
Common stock portion, number of stock for each share of progenics common stock (in shares) | shares	0.2502
Ownership percentage	35.00%
Business acquisition termination fee amount	$ 18.3
Merger agreement not to exceed	$ 5.3